Literature DB >> 1778887

Experience with liposomal amphotericin B (AmBisome) in cryptococcal meningitis in AIDS.

R J Coker1, S M Murphy, J R Harris.   

Abstract

Three patients with AIDS who had cryptococcal meningitis were treated with liposomal amphotericin B after unsuccessful treatment with fluconazole and conventional amphotericin B. One patient responded but relapsed nine weeks later; he responded to a second course of treatment but again relapsed and subsequently died. Another patient deteriorated despite an improvement in cryptococcal antigen titres. The third patient was found to have culture negative CSF and treatment was therefore stopped. None of the patients suffered any adverse effects and renal function improved in all after conventional amphotericin was stopped and liposomal amphotericin B commenced.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778887     DOI: 10.1093/jac/28.suppl_b.105

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.

Authors:  J W Lee; M A Amantea; P A Francis; E E Navarro; J Bacher; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

2.  In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex.

Authors:  K Mitsutake; S Kohno; Y Miyazaki; T Noda; H Miyazaki; T Miyazaki; M Kaku; H Koga; K Hara
Journal:  Mycopathologia       Date:  1994-10       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.